Latest Medical laboratory Stories
INDIANAPOLIS, Oct. 1, 2012 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has granted CLIA-waived status to the CoaguChek® XS Plus system, a point-of-care anticoagulation monitor that offers connectivity and data management tools to help healthcare professionals manage PT/INR (blood clotting time) testing. The waiver means that the monitoring technology may now be used in a broader range of clinical settings,...
SPARKS, Md., Oct. 1, 2012 /PRNewswire/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company), announced today that Paul Bourbeau, Ph.D. has joined the Company as Director, North American Scientific Affairs, BD Diagnostics - Diagnostic Systems. Dr. Bourbeau brings experience from an impressive career in academics and clinical laboratory practice, most recently serving as Director of Microbiology, Geisinger Medical Laboratories, Danville, PA. In his new role, Dr. Bourbeau...
UNION CITY, Calif., Sept. 13, 2012 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Severson, chairman and chief executive officer, will present at the UBS Global Life Sciences Conference on Wednesday, September 19, 2012 at 10:00 a.m. ET. The conference will be held at the Grand Hyatt New York Hotel in New York City. About AbaxisAbaxis develops, manufactures, markets and sells...
UNION CITY, Calif., Sept. 4, 2012 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Severson, chairman and chief executive officer, will present at the CL King's 10th Annual Best Ideas Conference 2012 on Wednesday, September 12, 2012 at 12:40 p.m. ET. The conference will be held at the Omni Berkshire Place Hotel in New York City. About AbaxisAbaxis develops, manufactures, markets...
UNION CITY, Calif., Aug. 30, 2012 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Severson, chairman and chief executive officer , will present at the Morgan Stanley Global Healthcare Conference on Tuesday, September 11, 2012 at 4:30 p.m. ET. The conference will be held at the Grand Hyatt New York in New York City. About AbaxisAbaxis develops, manufactures, markets and sells...
MADISON, N.J., Aug. 24, 2012 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, accepted a 2012 CIO 100 award from International Data Group's (IDG) CIO magazine for its Gazelle® mobile health application. The 25th annual award program recognizes organizations around the world that exemplify the highest level of operational and strategic excellence in information technology. The Gazelle mobile application for...
LEWISVILLE, Texas, Aug. 16, 2012 /PRNewswire/ -- ClearPoint Diagnostic Laboratories, which provides physicians with routine, anatomic and reference laboratory tests in a central Dallas Fort Worth location, is pleased to announce that it has become a United Healthcare Service Provider. United Healthcare will now cover esoteric and general laboratory tests, performed locally by ClearPoint in its 130,000 square foot facility, one of the largest labs in the Dallas Fort Worth area....
SHANGHAI, Aug. 16, 2012 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX) today announced that its toxicology facility in Suzhou had received a Certificate of Good Laboratory Practice (GLP) from the State Food and Drug Administration (SFDA) of the People's Republic of China after successfully passing two GLP inspections conducted by the SFDA. Good Laboratory Practice is a quality system concerned with the organizational processes and conditions under which health safety studies are...
UNION CITY, Calif., Aug. 8, 2012 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Severson, chairman and chief executive officer, will present at the Canaccord Genuity 32(nd) Annual Growth Conference on Wednesday, August 15, 2012 at 8:00 a.m. ET. The conference will be held at the InterContinental Boston Hotel in Boston, MA. About AbaxisAbaxis develops, manufactures, markets and...
MOUNTAIN VIEW, Calif., July 18, 2012 /PRNewswire/ -- The U.S. clinical laboratory market is on the cusp of radical changes, but it is unclear if these transitions will bring greater prosperity to the market or dampen its growth prospects. The market is assessing the impact of developments like Accountable Care Organizations (ACOs) and Food and Drug Administration (FDA) oversight on laboratory developed tests (LDTs). Further, the market is witnessing physician migration to hospitals,...
